Inhibitors of
3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), statins, which are used to prevent cardiovascular
diseases, are associated with a modest increase in the risk of new-onset
diabetes mellitus. To investigate the role of HMGCR in the development of β cells and glucose homeostasis, we deleted <i>Hmgcr</i> in a β cell-specific
manner by using the Cre-loxP technique. Mice lacking <i>Hmgcr</i> in β cells (β-KO) exhibited hypoinsulinemic hyperglycemia as
early as postnatal day 9 (P9) due to decreases in both β cell mass and insulin
secretion. Ki67 positive cells were reduced in β-KO mice at P9, thus β cell
mass reduction was caused by
proliferation disorder immediately after birth. The mRNA expression of <i>neurogenin3 (Ngn3)</i>, which is transiently expressed in endocrine
progenitors of the embryonic pancreas, was maintained despite a striking
reduction in the expression of β cell-associated genes, such as <i>insulin</i>, <i>Pancreatic and duodenal homeobox 1</i> <i>(Pdx1)</i> and <i>MAF
BZIP transcription factor A (</i><i>Mafa)</i>
in the islets from β-KO mice. Histological analyses revealed dysmorphic islets
with markedly reduced numbers of β cells,
some of which were also positive for glucagon. In conclusion, HMGCR
plays critical roles not only in insulin secretion but also in the development
of β cells in mice.